Feasibility of 68Ga-Labeled Fibroblast Activation Protein Inhibitor PET/CT in Light-Chain Cardiac Amyloidosis

X Wang, Y Guo, Y Gao, C Ren, Z Huang, B Liu… - Cardiovascular …, 2022 - jacc.org
Background Systemic amyloid light chain (AL) amyloidosis is the most common type of
amyloidosis, leading to cardiomyocyte necrosis and interstitial fibrosis. Gallium-68-labeled …

11C-Pittsburgh B PET Imaging in Cardiac Amyloidosis

SP Lee, ES Lee, H Choi, HJ Im, Y Koh, MH Lee… - JACC: Cardiovascular …, 2015 - jacc.org
Objectives: This study sought to investigate the efficacy of 11C-Pittsburgh B (PiB) positron
emission tomography (PET)/computed tomography (CT) in the diagnosis of cardiac …

Independent prognostic utility of 11C-Pittsburgh compound B PET in patients with light-chain cardiac amyloidosis

YJ Choi, Y Koh, HJ Lee, IC Hwang… - Journal of Nuclear …, 2022 - Soc Nuclear Med
11C-Pittsburgh compound B (PiB) PET/CT visualizes the amount of myocardial amyloid
deposit and can be used to prognosticate patients with amyloid light-chain (AL) cardiac …

[HTML][HTML] Diagnostic Value of 11C-PIB PET/MR in Cardiac Amyloidosis

X Bi, B Xu, J Liu, G Wang, J An, X Zhang… - Frontiers in …, 2022 - frontiersin.org
Background The thioflavin T derivative, 11C-Pittsburgh-B (PIB), is used for Alzheimer's
disease imaging because it specifically binds to β-amyloid protein deposits in the brain. The …

Detection of cardiac amyloidosis with 18F-Florbetaben-PET/CT in comparison to echocardiography, cardiac MRI and DPD-scintigraphy

M Kircher, S Ihne, J Brumberg, C Morbach… - European journal of …, 2019 - Springer
Purpose Cardiac amyloidosis (CA) is a rare cause of heart failure with frequently delayed
diagnosis, because specific early signs or symptoms are missing. Recently, direct amyloid …

[HTML][HTML] A Routine PET/CT Protocol with Streamlined Calculations for Assessing Cardiac Amyloidosis Using 18F-Florbetapir

DR Osborne, SN Acuff, A Stuckey… - Frontiers in cardiovascular …, 2015 - frontiersin.org
Introduction Cardiac amyloidosis is a rare condition characterized by the deposition of well-
structured protein fibrils, proteoglycans, and serum proteins as amyloid. Recent work has …

Improved quantification of cardiac amyloid burden in systemic light chain amyloidosis: redefining early disease?

SAM Cuddy, PE Bravo, RH Falk, S El-Sady… - Cardiovascular …, 2020 - jacc.org
Objectives The purpose of this study was to determine phenotypes characterizing cardiac
involvement in AL amyloidosis by using direct (fluorine-18-labeled florbetapir {[18F] …

Examining the sensitivity of 18F-NaF PET for the imaging of cardiac amyloidosis

P Martineau, V Finnerty, G Giraldeau, S Authier… - Journal of Nuclear …, 2021 - Elsevier
Background Conventional nuclear imaging with bone-seeking radiopharmaceuticals has
been shown to be a sensitive test for the detection of transthyretin cardiac amyloidosis …

Cardiac amyloidosis characterization by kinetic model fitting on [18F] florbetaben PET images

MF Santarelli, D Genovesi, M Scipioni… - Journal of Nuclear …, 2022 - Elsevier
Objective To evaluate the feasibility of kinetic modeling-based approaches from [18F]-
Flobetaben dynamic PET images as a non-invasive diagnostic method for cardiac …

18F-sodium fluoride PET/MRI myocardial imaging in patients with suspected cardiac amyloidosis

M Abulizi, I Sifaoui, M Wuliya-Gariepy… - Journal of Nuclear …, 2021 - Elsevier
Background We evaluated the diagnostic performance of 18 F-NaF PET/MRI in patients with
suspected cardiac amyloidosis (CA). Methods Twenty-seven consecutive patients …